{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 413884593
| IUPAC_name = 2-(diethylamino)ethyl hydroxy(diphenyl)acetate
| image = Benactyzine.svg
| width = 200
<!--Clinical data-->
| tradename =
| Drugs.com = {{drugs.com|international|benactyzine}}
| pregnancy_category =
| legal_status = Rx-only
| routes_of_administration = Oral
<!--Pharmacokinetic data-->
| bioavailability =
| metabolism =
| elimination_half-life =
| excretion =
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 302-40-9
| ATC_prefix = none
| ATC_suffix =
| PubChem = 9330
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB09023
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 8966
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 595EG71R3F
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07498
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 70352
<!--Chemical data-->
| C=20 | H=25
| N=1 | O=3
| molecular_weight = 327.417 g/mol
| smiles = O=C(OCCN(CC)CC)C(O)(c1ccccc1)c2ccccc2
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C20H25NO3/c1-3-21(4-2)15-16-24-19(22)20(23,17-11-7-5-8-12-17)18-13-9-6-10-14-18/h5-14,23H,3-4,15-16H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = IVQOFBKHQCTVQV-UHFFFAOYSA-N
}}
'''Benactyzine''' is an [[anticholinergic]] [[drug]] that was used as an [[antidepressant]] in the treatment of [[major depression|depression]] and associated [[anxiety]] before it was pulled from the U.S. market by the [[FDA]] due to its ineffectiveness.<ref name=Shorter>Shorter, E., Looking backwards: a possible new path for drug discovery in psychopharmacology. Nat Rev Drug Discov 2002, 1 (12), 1003â€“1006.</ref>

Its use for these indications was limited by [[side effect]]s such as [[dry mouth]] and [[nausea]], and at high doses it can cause more severe symptoms such as [[deliriant]] and [[hallucinogenic]] effects.<ref name=Shorter />

Brand names have included: '''Suavitil''', '''Phebex''', '''Phobex''', '''Cedad''', '''Cevanol''', '''Deprol''', '''Lucidil''', '''Morcain''', '''Nutinal''', '''Parasan'''. While there was some tentative evidence of effectiveness when combined with [[meprobamate]], with the medication no longer available it is not clinically important.<ref>{{cite book|last1=DeBattista|first1=Alan F. Schatzberg, Jonathan O. Cole, Charles|title=Manual of clinical psychopharmacology|date=2010|publisher=American Psychiatric Pub.|location=Washington, DC|isbn=978-1-58562-377-8|page=423|edition=7th|url=https://books.google.ca/books?id=D3zz1NCm3qcC&pg=PA423}}</ref>

== History ==
Benactyzine was brought to market in the US in 1957 by [[Merck & Co.|Merck]] under the tradename, Suavitil.<ref>Smith, Mickey C., PhD. [https://books.google.com/books?id=-5IABAAAQBAJ&pg=PA57&lpg=PA57&dq=merck+sharp+%26+dohme+Suavitil&source=bl&ots=o-__nOtxW-&sig=d_ZOTYTU4peJXm2rYHIbgEgct-w&hl=en&sa=X&ei=W3OIVO2kB8qnNq_KgqAD&ved=0CDIQ6AEwAw#v=twopage&q=suavitil&f=false Principles of Pharmaceutical Marketing], Third Edition. 3rd ed. New York: Routledge, 2013. Print. {{ISBN|978-1-317-94071-5}}</ref>

== References ==
{{Reflist}}

{{Antidepressants}}
{{Hallucinogens}}
{{Muscarinic acetylcholine receptor modulators}}

[[Category:Amines]]
[[Category:Deliriants]]
[[Category:Muscarinic antagonists]]


{{nervous-system-drug-stub}}